CompanyDrug

InnoCare Pharma and Keymed Biosciences Initiate Clinical Trial for ICP-B02 with First Subcutaneous Injection

CompanyDrug

Jiangsu Hengrui Medicine Gets NMPA Approval for HRS-4357 Clinical Study in Prostate Cancer

CompanyDrug

Sichuan Biokin Pharmaceutical Gets FDA Approval for BL-B01D1 Clinical Study

CompanyDrug

RareStone Group’s Pitolisant Earns Priority Review Status for Narcolepsy Treatment in China

CompanyDrug

Joincare Pharmaceutical Initiates Phase III Study for Anti-IL-17A mAb in Plaque Psoriasis

CompanyMedical Device

Bio-heart’s Iberis-HTN Study Shows Promising Results in Treating Primary Hypertension

CompanyDeals

Sisram Medical’s Alma Lasers Acquires PhotonMed International Ltd, Expanding Global Presence

CompanyDeals

Beijing Sun-Novo and Zhejiang Anglikang Enter Licensing Agreement for Hypertension Drug Candidate NHKC-1

CompanyDrug

ZSP1273 by Guangdong Zhongsheng Pharma Shows Promise in Phase III Flu Treatment Study

CompanyDrug

Hansoh Pharmaceutical’s Phenylheptal Peptide Receives NMPA Approval for Anemia Treatment